Assistance Publique Hopitaux De Paris

Research site

France Avenue Du 14 Juillet, 93140 Bondy, France

6 trials recruiting
Cryoglobulinaemia · Premature rupture of membranes · Kawasaki's disease
Adults and children

About Specializations

Assistance Publique Hopitaux De Paris in Bondy, France specialises in clinical trials of conditions such as Cryoglobulinaemia, Premature rupture of membranes, Kawasaki's disease, Hepatocellular carcinoma, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Avenue Du 14 Juillet93140 BondyFrance

Open in maps ↗

Recruiting now: 6 trials
Conditions studied: 13

More sites in Bondy France

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

10 clinical trials

Cryoglobulinaemia

Recruiting

Study of obinutuzumab treatment for patients with non-infectious cryoglobulinemia vasculitis who did not respond to or cannot tolerate rituximab

Registered drugNo placebo

Study of obinutuzumab treatment for patients with non-infectious cryoglobulinemia vasculitis who did not respond to or cannot tolerate rituximab

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Obinutuzumab
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Premature rupture of membranes

Recruiting

Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

Registered drug

Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

Registered drug

France

Participants:18–64 years
Substances:Nifedipine
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Kawasaki's disease

Recruiting

Comparing Anakinra versus Immunoglobulin for Treatment-Resistant Kawasaki Disease in Patients Who Failed Initial Immunoglobulin Therapy

Registered drugNo placebo

Comparing Anakinra versus Immunoglobulin for Treatment-Resistant Kawasaki Disease in Patients Who Failed Initial Immunoglobulin Therapy

Registered drugNo placebo

France

Participants:0–17 years
Substances:Anakinra
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Hepatocellular carcinoma

Recruiting

Study on Atezolizumab and Bevacizumab for Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

Registered drugNo placebo

Study on Atezolizumab and Bevacizumab for Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Centre Hospitalier Universitaire De Montpellier

Contact Research Centre

HIV infection+1

Recruiting

Study on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection

Registered drugNo placebo

Study on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection

Registered drugNo placebo

France

Participants:18–64 years
Substances:Darunavir
Sponsor:Inserm

Contact Research Centre

Hyponatraemia+1

Recruiting

Study on Using Desmopressin Acetate Trihydrate to Prevent Sodium Overcorrection in Patients with Severe Hyponatremia

Registered drugNo placebo

Study on Using Desmopressin Acetate Trihydrate to Prevent Sodium Overcorrection in Patients with Severe Hyponatremia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Glucose
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Abortion threatened

Not yet recruiting

Comparison of ceftriaxone and azithromycin versus amoxicillin and azithromycin for pregnant women with preterm premature rupture of membranes between 22 and 33 weeks.

Registered drugNo placebo

Comparison of ceftriaxone and azithromycin versus amoxicillin and azithromycin for pregnant women with preterm premature rupture of membranes between 22 and 33 weeks.

Registered drugNo placebo

France

Participants:18–64 years
Substances:Amoxicillin
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Osteomyelitis+1

Not recruiting

Study on Treating Acute Osteomyelitis in Children with Amoxicillin and Cloxacillin Compared to Standard Hospital Care

Registered drugNo placebo

Study on Treating Acute Osteomyelitis in Children with Amoxicillin and Cloxacillin Compared to Standard Hospital Care

Registered drugNo placebo

France

Participants:0–17 years
Substances:Amoxicillin
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Breast cancer female

Not recruiting

Study on Infertility Risk from Chemotherapy in Young Breast Cancer Patients Using Follitropin Beta and Follitropin Alfa for Egg/Embryo Preservation

Registered drugNo placebo

Study on Infertility Risk from Chemotherapy in Young Breast Cancer Patients Using Follitropin Beta and Follitropin Alfa for Egg/Embryo Preservation

Registered drugNo placebo

France

Participants:18–64 years
Substances:Follitropin Alfa
Sponsor:Centre Oscar Lambret

Contact Research Centre

Infertility

Not recruiting

Study on Improving Live Birth Rates in Women Under 37 with Infertility Using cpFT During ICSI

InvestigationalNo placebo

Study on Improving Live Birth Rates in Women Under 37 with Infertility Using cpFT During ICSI

InvestigationalNo placebo

France

Participants:18–64 years
Substances:Cpft Trifluoroacetate
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites